Post-Chemotherapy/Symptom Management Clinical Trials & Research at
Providence Medical Group
Post-chemotherapy symptom management trials focus on addressing the lingering
side effects and complications that cancer patients experience after completing
chemotherapy treatment. These studies aim to improve quality of life,
reduce long-term health impacts, and enhance recovery for cancer survivors.
Key aspects of these trials include:
- Targeting specific post-chemo symptoms (e.g., fatigue, cognitive impairment,
neuropathy)
- Testing various interventions (medications, lifestyle changes, complementary
therapies)
- Assessing both short-term relief and long-term outcomes
- Often involving multidisciplinary approaches
These trials are crucial for developing evidence-based strategies to manage
the often debilitating after-effects of chemotherapy, which can persist
for months or even years after treatment completion.
Providence Medical Group is currently enrolling patients for the following
post-chemotherapy/symptom management clinical trials:
Study for participants with painful post chemotherapy induced neuropathy
Treatment agent: Single cycle Tetrodotoxin
Physician: Dr Ian Anderson
Study Coordinator: Melissa Ulrich //
melissa.ulrich@providence.org // 707-521-3830
Study Resources:
Study Details | A Randomized, Double-Blind, Placebo Controlled, Multicenter,
Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment
of Chemotherapy Induced Neuropathic Pain | ClinicalTrials.gov
Sponsor: Wex Pharmaceuticals Inc.
Location: Providence Cancer Center, Santa Rosa, CA